MYCN and neuroblastoma: Here, we show that MILIP, an N-Myc-responsive lncRNA, promotes the NHEJ pathway through facilitating Ku70–Ku80 heterodimerization and is involved in the resistance to DNA-damaging therapeutics in neuroblastoma cells.